Evidence map›Paper›PMID 28003485›Full record

ArticleJournal of virology2017

Genesis and Dissemination of Highly Pathogenic H5N6 Avian Influenza Viruses.

Lei Yang, Wenfei Zhu, Xiaodan Li, Hong Bo, Ye Zhang, Shumei Zou, Rongbao Gao, Jie Dong, Xiang Zhao, Wenbing Chen and 5 more

Abstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lei YangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Wenfei ZhuNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Xiaodan LiNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Hong BoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Ye ZhangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Shumei ZouNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Rongbao GaoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Jie DongNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Xiang ZhaoNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Wenbing ChenNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Libo DongNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Xiaohui ZouNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Yongcai XingNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China.
Dayan WangNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China dayanwang@cnic.org.cn yshu@cnic.org.cn.
Yuelong ShuNational Institute for Viral Disease Control and Prevention, Collaboration Innovation Center for Diagnosis and Treatment of Infectious Diseases, Chinese Center for Disease Control and Prevention, and Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing, People's Republic of China dayanwang@cnic.org.cn yshu@cnic.org.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clade 2.3.4.4 highly pathogenic avian influenza viruses (H5Nx) have spread from Asia to other parts of the world. Since 2014, human infections with clade 2.3.4.4 highly pathogenic avian influenza H5N6 viruses have been continuously reported in China. To investigate the genesis of the virus, we analyzed 123 H5 or N6 environmental viruses sampled from live-poultry markets or farms from 2012 to 2015 in Mainland China. Our results indicated that clade 2.3.4.4 H5N2/N6/N8 viruses shared the same hemagglutinin gene as originated in early 2009. From 2012 to 2015, the genesis of highly pathogenic avian influenza H5N6 viruses occurred via two independent pathways. Three major reassortant H5N6 viruses (reassortants A, B, and C) were generated. Internal genes of reassortant A and B viruses and reassortant C viruses derived from clade 2.3.2.1c H5N1 and H9N2 viruses, respectively. Many mammalian adaption mutations and antigenic variations were detected among the three reassortant viruses. Considering their wide circulation and dynamic reassortment in poultry, we highly recommend close monitoring of the viruses in poultry and humans.

Indexed as

AnimalsChickensChinaDucksEvolution, MolecularGenes, ViralGenetic VariationInfluenza A virusInfluenza in BirdsPhylogenyPhylogeographyPoultry DiseasesSequence Analysis, DNAVirulenceH5N6highly pathogenic avian influenzareassortment

Identifiers

PMID28003485
PMCPMC5309950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.